The signal transducer and activator of transcription 1α and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: Involvement of p38 mitogen-activated protein kinase and nuclear factor-κB pathways, and synergistic effect of several proinflammatory cytokines

Journal of Biochemistry

Volumn 139, Issue 4, 2006, Pages 655-662

  Fujigaki, Hidetsugu ^a   Saito, Kuniaki ^a,b   Fujigaki, Suwako ^b   Takemura, Masao ^a   Sudo, Kaori ^a   Ishiguro, Hiroshi ^c   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c 1 5 5 Minatojima Minamimachi   (Japan)

Author keywords

Enzyme induction; Indoleamine 2,3 dioxygenase; Interferon regulatory factor 1; Lipopolysaccharide; Signal transducer and activator of transcription 1

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; OLIGONUCLEOTIDE PROBE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

CELL LINE; CELL LINE, TUMOR; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 33745654304     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvj072     Document Type: Article

References (31)

1. Yoshida, R., Park, S.W., Yasui, H., and Takikawa, O. (1988) Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141, 2819-2823
2. Saito, K., Nowak, T.S., Jr., Suyama, K., Quearry, B.J., Saito, M., Crowley, J.S., Markey, S.P., and Heyes, M.P. (1993) Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J. Neurochem. 61, 2061-2070
3. Heyes, M.P., Saito, K., Crowley, J.S., Davis, L.E., Demitrack, M. A., Der, M., Dilling, L.A., Elia, J., Kruesi, M.J., Lackner, A., et al. (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115 (Pt 5), 1249-1273
4. Takikawa, O., Habara-Ohkubo, A., and Yoshida, R. (1990) IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145, 1246-1250
5. Habara-Ohkubo, A., Shirahata, T., Takikawa, O., and Yoshida, R. (1993) Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase. Infect. Immun. 61, 1810-1813
6. Burke, F., Knowles, R.G., East, N., and Balkwill, F.R. (1995) The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo. Int. J. Cancer 60, 115-122
7. Saito, K., Crowley, J.S., Markey, S.P., and Heyes, M.P. (1993) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J. Biol. Chem. 268, 15496-15503
8. Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A.L., Munn, D.H., and Antonia, S.J. (2002) Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer 101, 151-155
9. Munn, D.H., Shafizadeh, E., Attwood, J.T., Bondarev, I., Pashine, A., and Mellor, A.L. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363-1372
10. Fujigaki, H., Saito, K., Lin, F., Fujigaki, S., Takahashi, K., Martin, B.M., Chen, C.Y., Masuda, J., Kowalak, J., Takikawa, O., Seishima, M., and Markey, S.P. (2006) Nitration and Inactivation of IDO by Peroxynitrite. J. Immunol. 176, 372-379
11. Thomas, S.R., Mohr, D., and Stocker, R. (1994) Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J. Biol. Chem. 269, 14457-14464
12. Morita, T., Saito, K., Takemura, M., Maekawa, N., Fujigaki, S., Fujii, H., Wada, H., Takeuchi, S., Noma, A., and Seishima, M. (2001) 3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma. Ann. Clin. Biochem. 38, 242-251
13. Hassanain, H.H., Chon, S.Y., and Gupta, S.L. (1993) Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor. J. Biol. Chem. 268, 5077-5084
14. Chon, S.Y., Hassanain, H.H., Pine, R., and Gupta, S.L. (1995) Involvement of two regulatory elements in interferon-gamma-regulated expression of human indoleamine 2,3-dioxygenase gene. J. Interferon Cytokine Res. 15, 517-526
15. Konan, K.V. and Taylor, M.W. (1996) Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene. J. Biol. Chem. 271, 19140-19145
16. Fujigaki, S., Saito, K., Sekikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., and Seishima, M. (2001) Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur. J. Immunol. 31, 2313-2318
17. Hissong, B.D. and Carlin, J.M. (1997) Potentiation of interferon-induced indoleamine 2,3-dioxygenase mRNA in human mononuclear phagocytes by lipopolysaccharide and interleukin-1. J. Interferon Cytokine Res. 17, 387-393
18. Saito, K., Suyama, K., Nishida, K., Sei, Y., and Basile, A.S. (1996) Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206, 149-152
19. Heyes, M.P., Saito, K., and Markey, S.P. (1992) Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 283 (Pt 3), 633-635
20. Alberati-Giani, D. and Cesura, A.M. (1998) Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators. Amino Acids 14, 251-255
21. Orabona, C., Puccetti, P., Vacca, C., Bicciato, S., Luchini, A., Fallarino, F., Bianchi, R., Velardi, E., Perruccio, K., Velardi, A., Bronte, V., Fioretti, M.C., and Grohmann, U. (2005) Towards the identification of a tolerogenic signature in IDO-competent dendritic calls. Blood (in press)
22. Heyes, M.P., Chen, C.Y., Major, E.O., and Saito, K. (1997) Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem. J. 326 (Pt 2), 351-356
23. Seishima, M., Takemura, M., Saito, K., and Kitajima, Y. (1998) Increased serum soluble Fas, tumor necrosis factor alpha and interleukin 6 concentrations in generalized pustular psoriasis. Dermatology 196, 371-372
24. FitzGerald, M.J., Webber, E.M., Donovan, J.R., and Fausto, N. (1995) Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ. 6, 417-127
25. Musso, T., Gusella, G.L., Brooks, A., Longo, D.L., and Varesio, L. (1994) Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 83, 1408-1411
26. Yuan, W., Collado-Hidalgo, A., Yufit, T., Taylor, M., and Varga, J. (1998) Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J. Cell Physiol. 177, 174-186
27. Terness, P., Bauer, T.M., Rose, L., Dufter, C., Watzlik, A., Simon, H., and Opelz, G. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447-457
28. Wolf, A.M., Wolf, D., Rumpold, H., Moschen, A.R., Kaser, A., Obrist, P., Fuchs, D., Brandacher, G., Winkler, C., Geboes, K., Rutgeerts, P., and Tilg, H. (2004) Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin. Immunol. 113, 47-55
29. Ajizian, S.J., English, B.K., and Meals, E.A. (1999) Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J. Infect. Dis. 179, 939-944
30. Wang, S.W., Pawlowski, J., Wathen, S.T., Kinney, S.D., Lichenstein, H.S., and Manthey, C.L. (1999) Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. Res. 48, 533-538
31. Ropert, C., Almeida, I.C., Closel, M., Travassos, L.R., Ferguson, M.A., Cohen, P., and Gazzinelli, R.T. (2001) Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J. Immunol. 166, 3423-3431